Paul R. Hansen - Nov 9, 2021 Form 4 Insider Report for Vyant Bio, Inc. (VYNT)

Role: Director
Signature: /s/ Andrew LaFrence, attorney-in-fact
Stock symbol: VYNT
Transactions as of: Nov 9, 2021
Transactions value $: $0
Form type: 4
Date filed: 2/27/2023, 04:41 PM
Previous filing: Aug 23, 2021
Next filing: Jan 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNT	Common Stock, $0.0001 par value	Will/Inheritance	$0	+6.78K	+4.43%	$0.00	160K	Nov 9, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 9, 2021, the Reporting Person inherited 6,783 shares of common stock.

Remarks:

The shares reported on this Form 4 have been adjusted to reflect the Issuer's 1-for-5 reverse stock split of its common stock, effective November 2, 2022.